Literature DB >> 6300551

Hypercalcemia in dogs with adenocarcinoma derived from apocrine glands of the anal sac. Biochemical and histomorphometric investigations.

D J Meuten, G V Segre, C C Capen, G J Kociba, E F Voelkel, L Levine, A H Tashjian, D J Chew, L A Nagode.   

Abstract

Hypercalcemia, hypercalciuria, and hyperphosphaturia were present in female dogs with adenocarcinomas derived from apocrine glands of the anal sac (CA). Remission of hypercalcemia accompanied tumor excision in all six dogs undergoing surgery, whereas tumor recurrence or growth of metastases was associated with a return of hypercalcemia. Preoperatively, the plasma concentrations of immunoreactive parathyroid hormone in all dogs were undetectable or in the low normal range. Plasma concentrations of 13,14-dihydro-15-keto-prostaglandin E2 (PGE2M) and serum 1,25-dihydroxyvitamin D were not significantly different from control dogs. Urinary cyclic AMP and hydroxyproline were increased in dogs with CA. No immunoreactive parathyroid hormone was detected in extracts from tumor tissue, and parathyroid glands from dogs with CA had ultrastructural characteristics of secretory inactivity. Lumbar vertebrae from hypercalcemic dogs had decreased trabecular bone volume and increased osteoclastic bone resorption compared with age-matched control dogs. After tumor excision, serum total calcium returned to the normal range, whereas immunoreactive parathyroid hormone increased 2- to 20-fold and 1,25-dihydroxyvitamin D decreased 2- to 8-fold. Postoperative hypocalcemia was not observed. These results indicate that CA produces a hypercalcemic factor other than immunoreactive parathyroid hormone or prostaglandin E2 that increases osteoclastic osteolysis distant from the tumor and results in hypercalcemia, hypercalciuria, and hyperphosphaturia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300551

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  Malignant Neoplasia of the Sex Skin in 2 Chimpanzees (Pan troglodytes).

Authors:  Amanda P Beck; Elizabeth R Magden; Stephanie J Buchl; Wallace B Baze
Journal:  Comp Med       Date:  2016-04       Impact factor: 0.982

2.  Clinical hypocalcemia following surgical resection of apocrine gland anal- sac adenocarcinomas in 3 dogs.

Authors:  Jaime A Olsen; Julia P Sumner
Journal:  Can Vet J       Date:  2019-06       Impact factor: 1.008

3.  Paraneoplastic hypercalcemia in a dog with thyroid carcinoma.

Authors:  Amy E Lane; Kenneth M Wyatt
Journal:  Can Vet J       Date:  2012-10       Impact factor: 1.008

4.  In vitro bone resorption activity produced by a hypercalcemic adenocarcinoma tumor line (CAC-8) in nude mice.

Authors:  T J Rosol; C C Capen; C Minkin
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

5.  Complications associated with iliosacral lymphadenectomy in dogs with metastatic apocrine gland anal sac adenocarcinoma.

Authors:  Yael Huerta; Carlos H De Mello Souza; Laura E Selmic; Alysha McGrath; Owen T Skinner; Katelin V Dark; Marine Traverson; William L Snell; Elizabeth A Maxwell; Judith Bertran; Michelle M M Hasiuk
Journal:  Can Vet J       Date:  2022-09       Impact factor: 1.075

6.  Adenylate cyclase-stimulating, bone-resorbing and B TGF-like activities in canine apocrine cell adenocarcinoma of the anal sac.

Authors:  E C Weir; M Centrella; R E Matus; M L Brooks; T Wu; K L Insogna
Journal:  Calcif Tissue Int       Date:  1988-12       Impact factor: 4.333

7.  Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy.

Authors:  K Ikeda; M Mangin; B E Dreyer; A C Webb; J T Posillico; A F Stewart; N H Bander; E C Weir; K L Insogna; A E Broadus
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.